Pharming Group Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	867	977	627	690	707	503
Market Cap Growth	35.79%	55.71%	-9.08%	-2.41%	40.66%	-38.05%
Enterprise Value	820	947	587	658	657	487
Last Close Price	1.23	1.43	0.93	1.03	1.08	0.78
PE Ratio	86.75	402.37	-	-	55.27	35.75
Forward PE	43.74	-	-	153.88	27.10	14.49
PS Ratio	2.71	3.05	2.19	3.11	3.68	2.88
PB Ratio	3.72	4.14	2.94	3.49	3.69	2.96
P/TBV Ratio	7.24	8.10	4.06	5.17	5.82	5.23
P/FCF Ratio	17.94	21.26	-	-	35.85	21.10
P/OCF Ratio	17.71	20.97	-	-	33.66	15.11
EV/Sales Ratio	2.56	2.96	2.05	2.97	3.41	2.78
EV/EBITDA Ratio	20.45	28.07	188.69	-	40.97	18.22
EV/EBIT Ratio	26.73	33.94	-	-	67.70	23.07
EV/FCF Ratio	16.97	20.61	-	-	33.29	20.43
Debt / Equity Ratio	0.43	0.42	0.51	0.78	0.82	0.84
Debt / EBITDA Ratio	2.54	2.69	17.02	-	8.46	4.88
Debt / FCF Ratio	2.09	2.15	-	-	7.91	5.97
Net Debt / Equity Ratio	-0.20	-0.23	-0.25	-0.19	-0.20	-0.16
Net Debt / EBITDA Ratio	-1.28	-1.60	-17.24	2.74	-2.37	-0.99
Net Debt / FCF Ratio	-0.97	-1.17	21.50	2.24	-1.93	-1.11
Asset Turnover	0.83	0.84	0.69	0.55	0.50	0.49
Inventory Turnover	0.71	0.75	0.63	0.51	0.50	0.87
Quick Ratio	2.05	1.97	2.96	3.28	3.90	4.69
Current Ratio	2.63	2.59	3.77	4.06	4.65	5.33
Return on Equity (ROE)	5.04%	1.02%	-5.38%	-4.98%	6.88%	8.50%
Return on Assets (ROA)	4.89%	4.55%	-0.52%	-3.06%	1.57%	3.68%
Return on Invested Capital (ROIC)	10.00%	3.41%	-2.10%	-12.76%	5.79%	10.98%
Return on Capital Employed (ROCE)	9.30%	8.50%	-1.10%	-5.70%	2.80%	6.80%
Earnings Yield	1.24%	0.25%	-1.82%	-1.38%	1.81%	2.80%
FCF Yield	5.57%	4.70%	-0.40%	-2.46%	2.79%	4.74%
Buyback Yield / Dilution	-13.48%	-11.25%	-2.18%	7.09%	-0.85%	-2.70%